Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate
Clinical trial NCT00085228 · COMPLETED
Trial details
- NCT number
- NCT00085228
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2006-01-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.